World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
122
Citations
72486
World Ranking
3418
National Ranking
1882

Overview

Ian M. Thompson is affiliated with The University of Texas Health Science Center at San Antonio in the United States. Their research spans various fields of medicine, with a strong emphasis on pulmonary and respiratory medicine, surgery, oncology, molecular biology, and cancer research.

Their main fields of study include:

  • Medicine

Within medicine, the scientist's work extends to the following subfields:

  • Pulmonary and Respiratory Medicine
  • Surgery
  • Oncology
  • Molecular Biology
  • Cancer Research

The research topics frequently addressed in their publications include:

  • Prostate Cancer Treatment and Research
  • Prostate Cancer Diagnosis and Treatment
  • Bladder and Urothelial Cancer Treatments
  • Radiopharmaceutical Chemistry and Applications
  • Renal Cell Carcinoma Treatment
  • Urinary and Genital Oncology Studies
  • Cancer Genomics and Diagnostics

Ian M. Thompson has published extensively in several journals and publication outlets, with notable frequent venues such as:

  • Journal of Clinical Oncology
  • The Journal of Urology
  • European Urology
  • arXiv (Cornell University)
  • UNC Libraries

Some of their recent papers include:

  • Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction, 2021, Nature Genetics
  • Cardiovascular Safety of Testosterone-Replacement Therapy, 2023, New England Journal of Medicine
  • Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening, 2023, The Journal of Urology
  • A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial, 2021, The Lancet
  • Early Detection of Prostate Cancer: AUA/SUO Guideline Part II: Considerations for a Prostate Biopsy, 2023, The Journal of Urology

The scientist collaborates frequently with a core group of co-authors, including:

  • Catherine M. Tangen
  • Melissa Plets
  • Phyllis J. Goodman
  • Seth P. Lerner
  • Primo N. Lara

Best Publications

  • The Influence of Finasteride on the Development of Prostate Cancer

    Ian M. Thompson;Phyllis J. Goodman;Catherine M. Tangen;M. Scott Lucia

  • Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter

    Ian M. Thompson;Donna K. Pauler;Phyllis J. Goodman;Catherine M. Tangen

  • Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

    Scott M. Lippman;Eric A. Klein;Eric A. Klein;Phyllis J. Goodman;M. Scott Lucia

  • Vitamin E and the Risk of Prostate Cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)

    Eric A. Klein;Ian M. Thompson;Catherine M. Tangen;John J. Crowley

  • Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations

    Cong-Yi Wang;Eberhard Nieschlag;Ronald Swerdloff;Hermann Behre

  • Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial

    Ian M. Thompson;Catherine M. Tangen;Jorge Paradelo;M. Scott Lucia

  • American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010

    Andrew M.D. Wolf;Richard C. Wender;Ruth B. Etzioni;Ian M. Thompson

  • Erectile Dysfunction and Subsequent Cardiovascular Disease

    Ian M. Thompson;Catherine M. Tangen;Phyllis J. Goodman;Jeffrey L. Probstfield

  • Bilateral orchiectomy with or without flutamide for metastatic prostate cancer

    Mario A. Eisenberger;Brent A. Blumenstein;E. David Crawford;Gary Miller

  • Assessing Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial

    Ian M. Thompson;Donna Pauler Ankerst;Chen Chi;Phyllis J. Goodman

  • Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial.

    Ian M. Thompson;Catherine M. Tangen;Jorge Paradelo;M. Scott Lucia

  • Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

    Jyoti D. Patel;Lada Krilov;Sylvia Adams;Carol Aghajanian

  • Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower.

    Ian M. Thompson;Donna Pauler Ankerst;Chen Chi;M. Scott Lucia

  • Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

    Fredrick R. Schumacher;Ali Amin Al Olama;Sonja I. Berndt;Sara Benlloch

  • Investigation, treatment and monitoring of late-onset hypogonadism in males

    Cong-Yi Wang;Eberhard Nieschlag;Ronald Swerdloff;Hermann Behre

  • Variation in the Definition of Biochemical Recurrence in Patients Treated for Localized Prostate Cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel Report and Recommendations for a Standard in the Reporting of Surgical Outcomes

    Michael S. Cookson;Gunnar Aus;Arthur L. Burnett;Edith D. Canby-Hagino

  • Rethinking screening for breast cancer and prostate cancer

    Laura Esserman;Yiwey Shieh;Ian Thompson

  • Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial

    Dipen J Parekh;Isildinha M Reis;Erik P Castle;Mark L Gonzalgo

  • ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males.

    Cong-Yi Wang;Eberhard Nieschlag;Ronald Swerdloff;Hermann Behre

  • Intermittent versus continuous androgen deprivation in prostate cancer.

    Maha Hussain;Catherine M. Tangen;Donna L. Berry;Celestia S. Higano

Frequent Co-Authors

Catherine M. Tangen
Catherine M. Tangen Fred Hutchinson Cancer Research Center
Robin J. Leach
Robin J. Leach The University of Texas Health Science Center at San Antonio
Daniel W. Lin
Daniel W. Lin University of Washington
Peter R. Carroll
Peter R. Carroll University of California, San Francisco
Eric A. Klein
Eric A. Klein Cleveland Clinic
Elizabeth A. Platz
Elizabeth A. Platz Johns Hopkins University
Scott M. Lippman
Scott M. Lippman University of California, San Diego
Nicholas J. Vogelzang
Nicholas J. Vogelzang University of Nevada Reno
Maha Hussain
Maha Hussain Northwestern University
James D. Brooks
James D. Brooks Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in other routes into the healthcare field or considering flexible study options? There are many online dnp programs without clinicals for those aiming to advance in nursing practice and leadership, offering greater flexibility for working professionals.

For those seeking a faster entry into the nursing profession, a 9 month lpn program can be a cost-efficient choice, making it possible to start working in healthcare sooner. Licensed Practical Nurse (LPN) programs are ideal for those wanting a quicker pathway to direct patient care.

If you're already a registered nurse with a master's degree, you might consider the shortest post master's pmhnp online programs to specialize in psychiatric mental health care. These fast-track options can help you launch a new career focus quickly.

Prefer to work on the administrative side of healthcare? An accredited health care administration degree online is a smart pathway to leadership roles, enabling you to manage healthcare institutions or systems efficiently.

Best Scientists Citing Ian M. Thompson

Trending Scientists